Physician

Mark P Dacey, M.D.

According to 2025 Medicare claims, Mark Dacey, M.D. (NPI: 1184613192) practices ophthalmology in the Boston, MA market, with the plurality of this provider's patient population coming from Plymouth, MA. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF BOSTON, INC. (NPI: 1932146594; TIN: 04-2500346) and primary practice location at 02189-3110. Dacey is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Dacey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,065 traditional Medicare patients, billed 21,049 HCPCS/CPT codes, and received $2,543,687 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 432 prescription claims across 123 beneficiaries totaling $11,203 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 4 records totaling $251. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $15,404 and ending at $11,203. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,802	8,492	$1,493,943
2016	1,635	8,796	$1,699,656
2017	1,680	9,539	$1,865,852
2018	1,817	11,908	$1,975,247
2019	1,767	12,306	$1,995,914
2020	1,519	11,220	$1,913,063
2021	1,732	12,018	$1,911,370
2022	1,866	13,778	$2,099,644
2023	1,972	16,980	$2,240,593
2024	2,065	21,049	$2,543,687

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	89	295	$15,404
2016	96	351	$20,750
2017	80	275	$14,625
2018	92	306	$14,378
2019	93	299	$15,727
2020	80	307	$13,004
2021	98	364	$14,538
2022	128	459	$20,406
2023	106	351	$13,442
2024	123	432	$11,203

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	379	1,667	$93
92014	Established patient complete exam of visual system	1,809	2,100	$93
92012	Established patient problem focused exam of visual system	258	381	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	237	336	$70
92134	Imaging of retina	1,961	3,995	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	153	4,164	$5,034
Atropine Sulfate	Atropine Sulfate	69	1,374	$1,578
Ofloxacin	Ofloxacin	72	1,365	$683
Brimonidine Tartrate	Brimonidine Tartrate	44	1,492	$370
Latanoprost	Latanoprost	33	1,560	$365

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$251	Alimera Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark P. Dacey, M.D.?

Tedicare shows public-source Medicare data for Mark P. Dacey, M.D. (NPI 1184613192), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark P. Dacey, M.D. have ACO affiliation data?

Mark P. Dacey, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Mark P. Dacey, M.D.?

Mark P. Dacey, M.D. is linked to OPHTHALMIC CONSULTANTS OF BOSTON, INC. (billing NPI 1932146594) in the available physician profile data.

Does Mark P. Dacey, M.D. have Open Payments data?

Mark P. Dacey, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.